North Star Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.7K | Hold |
42
| – | – | ﹤0.01% | 797 |
|
|
2025
Q1 | $20.4K | Hold |
42
| – | – | ﹤0.01% | 753 |
|
|
2024
Q4 | $16.9K | Buy |
42
+13
| +45% | +$5.24K | ﹤0.01% | 787 |
|
|
2024
Q3 | $13.5K | Buy |
29
+14
| +93% | +$6.51K | ﹤0.01% | 783 |
|
|
2024
Q2 | $7.03K | Hold |
15
| – | – | ﹤0.01% | 871 |
|
|
2024
Q1 | $6.27K | Hold |
15
| – | – | ﹤0.01% | 943 |
|
|
2023
Q4 | $6.1K | Hold |
15
| – | – | ﹤0.01% | 921 |
|
|
2023
Q3 | $5.22K | Hold |
15
| – | – | ﹤0.01% | 952 |
|
|
2023
Q2 | $5.28K | Hold |
15
| – | – | ﹤0.01% | 962 |
|
|
2023
Q1 | $4.73K | Hold |
15
| – | – | ﹤0.01% | 995 |
|
|
2022
Q4 | $4.33K | Buy |
15
+10
| +200% | +$2.89K | ﹤0.01% | 986 |
|
|
2022
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 1108 |
|
|
2022
Q2 | $1K | Hold |
5
| – | – | ﹤0.01% | 1111 |
|
|
2022
Q1 | $1K | Hold |
5
| – | – | ﹤0.01% | 1127 |
|
|
2021
Q4 | $1K | Sell |
5
-70
| -93% | -$14K | ﹤0.01% | 1156 |
|
|
2021
Q3 | $14K | Hold |
75
| – | – | ﹤0.01% | 806 |
|
|
2021
Q2 | $15K | Buy |
+75
| New | +$15K | ﹤0.01% | 787 |
|
|
2019
Q4 | – | Sell |
-8
| Closed | -$1K | – | 1100 |
|
|
2019
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 1069 |
|
|
2015
Q4 | – | Sell |
-151
| Closed | -$16K | – | 851 |
|
|
2015
Q3 | $16K | Hold |
151
| – | – | ﹤0.01% | 533 |
|
|
2015
Q2 | $19K | Hold |
151
| – | – | ﹤0.01% | 499 |
|
|
2015
Q1 | $18K | Hold |
151
| – | – | ﹤0.01% | 501 |
|
|
2014
Q4 | $18K | Buy |
+151
| New | +$18K | ﹤0.01% | 493 |
|